What Makes X-Chem’s DNA-Encoded Library Better?
No other partner understands DEL like X-Chem — our experts pioneered DEL-driven drug discovery.
X‑Chem scientists know what makes a developable small molecule drug lead. While others may tout the tremendous size of their libraries, at X‑Chem we understand that library size, chemical diversity and compound properties work together to maximize the odds of successful lead generation. Our libraries are designed to achieve the optimal balance of physicochemical properties and chemical diversity by using schemes with maximum atom economy.
When you work with X-Chem, you are assured access to the very best small molecule libraries and the leading DEL platform. Our goal is to drive your project success.
ReadiDEL Libraries Identify Better Small Molecule Drug Hits
X-Chem’s industry-leading screening resource with unrivaled productivity is your solution for rapidly building a drug discovery pipeline. ReadiDEL libraries represent the newest in X-Chem’s industry-leading DEL design concepts, with a focus on atom economy and developability.
When you identify hits with ReadiDEL, they have properties well-suited for further lead optimization in your drug discovery process. In addition, the ReadiDELs produce an in-depth DEL dataset, which provides insight about structure-activity relationships for effectively binding to your target.
Advanced ReadiDEL library characteristics:
- Progressive DEL design concepts
- Informed by many years of DEL performance
- Drug-like molecular properties
- Focused on developability
- Billions of compounds and growing
- Add-on services available like target protein QC, compound synthesis and hit testing
- Optional hit-to-lead and lead optimization partnerships to convert leads into clinical candidates